The peptide party got cancelled. The grey market did not
Headline by Prism · from 1 report
A planned promotional event for peptides in Bengaluru was cancelled following public backlash and regulatory scrutiny amidst a growing grey market for the substances.
MintThe brief
Written by software from the 1 report below.
- Organizers cancelled a planned event in Bengaluru after it drew public criticism for promoting unapproved drugs.
- Consumers in India are increasingly purchasing peptides online for uses ranging from weight loss to muscle recovery.
- These substances are often marketed as being for research use only to bypass regulatory oversight.
- Medical professionals warn that using these compounds without clinical trials or medical supervision poses significant health risks.
What to watch next
- Ongoing regulatory monitoring of online peptide sales by Indian health authorities
- Developments in the Indian market as local firms prepare for potential regulatory shifts
- The prevalence of contamination in grey-market peptide products sourced from local vendors
The points restate the reports; where one says why it matters, that is Prism's reading, not a reported fact.
Who said what
4 quotes · 1 outlet
Only words found exactly in the article are shown, attributed and linked to the line they came from.
Aisurya Mishra
brand strategist at Upsurge Labs
1 quote · 1 outlet
“The peptide party was conceived as a way to start a conversation, not as a product launch or a clinic”
In the article
…and tap into a growing trend, the organisers told Mint. “India’s first peptide party”, as it was marketed, was following a wave of peptide clubs, ‘raves’ and workshops in San Francisco’s longevity circles. “ The peptide party was conceived as a way to start a conversation, not as a product launch or a clinic ,” Aisurya Mishra, brand strategist at Upsurge Labs, which organised the event, told Mint. “India in general has been a little behind when it comes to biotech and biological science conversations that are already…
P.T. Rajesh
body transformation specialist and gym owner
1 quote · 1 outlet
“If you are using them cautiously and you know what you are doing, you can use them without any issues”
In the article
…Rajesh uses GHK-Cu for skin and hair benefits. A 25mg vial, he says, costs around ₹11,000. The fact that these products carry labels such as “not for human consumption” or “research use only” does not concern him. “ If you are using them cautiously and you know what you are doing, you can use them without any issues ,” he says. Finding such peptides is not difficult. “Sellers are everywhere,” he says. “People who import protein supplements are usually the ones, as it’s easy for them to get it in.” For another cohort using…
Karan
wellness clinic owner
1 quote · 1 outlet
“Vendors are nothing but local dealers and chemists who import it, repackage it and sell it online… so far, we have fired five dealers after finding contamination in the product”
In the article
…Bengaluru, started commercial exploration of peptides in 2019, but struggled finding vendors. The clinic offers peptides to select clients as part of larger packages, after a host of diagnostic tests to ensure safety. “ Vendors are nothing but local dealers and chemists who import it, repackage it and sell it online… so far, we have fired five dealers after finding contamination in the product ,” says Karan, who asked to be identified by his first name. Vendors import peptide active pharmaceutical ingredients—or APIs, the main raw material in a medicine that produces its intended therapeutic effect—from…
Anshu Shrivastava
director of strategy and corporate development, HRV Pharma
1 quote · 1 outlet
“We have been working with certain manufacturers in anticipation of this ruling from the FDA. Our initial test batches are already in place”
In the article
…pharmacists combine ingredients to create custom medications—are a mainstay in the US. India doesn’t have a framework regulating compounding. But some Indian firms have taken note of the development in the US. “ We have been working with certain manufacturers in anticipation of this ruling from the FDA. Our initial test batches are already in place ,” says Anshu Shrivastava, director of strategy and corporate development, HRV Pharma. The proprietary drug-development platform recently signed a deal with Hyderabad-based Arene Life Sciences to jointly invest ₹50…
Coverage
1 outlet
All filed from India
NamedIndia · United States · China · Aisurya Mishra · Anshu Shrivastava · Arene Life Sciences · Central Drugs Standard Control Organisation · Eli Lilly · Food Safety and Standards Authority of India · HRV Pharma · Joe Rogan · Karan · Novo Nordisk · P.T. Rajesh · Robert F. Kennedy Jr.
The 1 report is listed beside the record.
Corrections and versions
A correction says what was wrong and why. Every earlier headline and brief of this record is kept.
Something wrong?
Say what, and it arrives with this record's address filled in. A correction is welcome.
Ask this story
Answers cite the 1 report above, or say they can't.